Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
The purpose of this study is to investigate and evaluate the effects of liraglutide combined with short-term continuous subcutaneous insulin infusion(CSII) on long-term glycemic control and β-cell function in newly diagnosed type 2 diabetic patients.
Epistemonikos ID: 0be68da50e726c9e9ab85fe21b4c65a5cdeea7f6
First added on: May 11, 2024